Published in Scand J Infect Dis on January 01, 1983
Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patients. J Clin Microbiol (2005) 1.41
Diagnosis of pneumococcal pneumonia by enzyme-linked immunosorbent assay of antibodies to pneumococcal hemolysin (pneumolysin). J Clin Microbiol (1987) 1.35
Sputum gram's stain in community-acquired pneumococcal pneumonia. A meta-analysis. West J Med (1996) 1.26
Sputum gram stain assessment in community-acquired bacteremic pneumonia. J Clin Microbiol (1988) 1.14
Real-time PCR for detection and differentiation of gram-positive and gram-negative bacteria. J Clin Microbiol (2002) 1.14
Simple method for quantifying viable bacterial numbers in sputum. J Clin Pathol (1995) 1.13
Danger of sputum purulence screens in culture of Legionella species. J Clin Microbiol (1994) 1.13
Comparison of sputum and nasopharyngeal aspirate samples and of the PCR gene targets lytA and Spn9802 for quantitative PCR for rapid detection of pneumococcal pneumonia. J Clin Microbiol (2013) 1.09
Etiologic diagnosis of adult bacterial pneumonia by culture and PCR applied to respiratory tract samples. J Clin Microbiol (2006) 1.08
Detection of C polysaccharide in Streptococcus pneumoniae in the sputa of pneumonia patients by an enzyme-linked immunosorbent assay. J Clin Microbiol (1985) 1.07
Conformity of bacterial growth in sputum and contamination free endobronchial samples in patients with cystic fibrosis. Thorax (1986) 1.02
Minimum number of pneumococci required for capsular antigen to be detectable by latex agglutination. J Clin Microbiol (1992) 1.00
Sampling variability in the microbiological evaluation of expectorated sputa and endotracheal aspirates. J Clin Microbiol (2001) 0.95
Utility of gram stain in evaluation of sputa from patients with cystic fibrosis. J Clin Microbiol (1994) 0.93
Antibiotic resistance of clinical isolates of Streptococcus pneumoniae in Greece. J Clin Microbiol (1994) 0.92
Usefulness of Gram stain for diagnosis of lower respiratory tract infection or urinary tract infection and as an aid in guiding treatment. Eur J Clin Microbiol Infect Dis (2003) 0.89
Mechanisms to assess Gram stain interpretation proficiency of technologists at satellite laboratories. J Clin Microbiol (2007) 0.88
Effect of antimicrobial use on pneumococcal diagnostic tests in elderly patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis (2014) 0.88
Randomized trial interpreting sputum quality in a clinical laboratory. J Clin Microbiol (1987) 0.83
Relation between beta-lactamase producing bacteria and patient characteristics in chronic obstructive pulmonary disease (COPD). Thorax (1995) 0.81
Pneumococci in nasopharyngeal samples from Filipino children with acute respiratory infections. J Clin Microbiol (1994) 0.81
Association between serotype-specific antibody response and serotype characteristics in patients with pneumococcal pneumonia, with special reference to degree of encapsulation and invasive potential. Clin Vaccine Immunol (2014) 0.80
Molecular incidence and clearance of Plasmodium falciparum infection. Malar J (2015) 0.77
Clinical and Microbiological Factors Associated with High Nasopharyngeal Pneumococcal Density in Patients with Pneumococcal Pneumonia. PLoS One (2015) 0.75
Evaluation of five test-kits-API, AuxoTab, Enterotube, PathoTec and R-B-for identification of Enterobacteriaceae. Med Microbiol Immunol (1974) 8.61
Bacteriophage receptors. Annu Rev Microbiol (1973) 4.45
Titration of antibodies to salmonella O antigens by enzyme-linked immunosorbent assay. Infect Immun (1972) 4.13
Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet (1990) 3.55
Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr Top Microbiol Immunol (1992) 3.03
Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J Clin Invest (1987) 3.03
Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis (2006) 3.01
Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J Biol Chem (1987) 3.00
Enzyme-linked immunosorbent assay (ELISA) for titration of antibodies against Brucella abortus and Yersinia enterocolitica. Acta Pathol Microbiol Scand C (1976) 2.77
Structural studies on the hexose region of the core in lipopolysaccharides from Enterobacteriaceae. Eur J Biochem (1981) 2.47
Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium. Infect Immun (1979) 2.21
Deaths in bacteremic pneumococcal pneumonia. A comparison of two populations--Huntington, WVa, and Stockholm, Sweden. Chest (1993) 2.17
Clinical evaluation of minocycline. Antimicrob Agents Chemother (Bethesda) (1968) 2.14
Characterization of repetitive sequences controlling phase variation of Haemophilus influenzae lipopolysaccharide. J Bacteriol (1990) 2.08
Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J Infect Dis (1994) 2.03
Evaluation of some extraction methods for the preparation of bacterial lipopolysaccharides for structural analysis. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 2.02
Enzyme-linked immunosorbent assay for immunological diagnosis of human tularemia. J Clin Microbiol (1979) 1.99
Phage typing of Shigella sonnei. Arch Immunol Ther Exp (Warsz) (1968) 1.90
Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect Immun (1995) 1.88
Rapid and sensitive detection of Salmonella (O:6,7) by immunomagnetic monoclonal antibody-based assays. J Immunol Methods (1991) 1.86
Salmonella typhimurium mutants defective in UDP-D-galactose:lipopolysaccharide alpha 1,6-D-galactosyltransferase. Structural, immunochemical, and enzymologic studies of rfaB mutants. J Biol Chem (1983) 1.82
Monoclonal antibodies specific for Shigella flexneri lipopolysaccharides: clones binding to type I and type III:6,7,8 antigens, group 6 antigen, and a core epitope. Infect Immun (1986) 1.81
Salmonella typhimurium infection in calves: protection and survival of virulent challenge bacteria after immunization with live or inactivated vaccines. Infect Immun (1983) 1.81
Glycosyl transferases of O-antigen biosynthesis in Salmonella enterica: identification and characterization of transferase genes of groups B, C2, and E1. J Bacteriol (1993) 1.74
Chemical structure of the lipopolysaccharide of Haemophilus influenzae strain I-69 Rd-/b+. Description of a novel deep-rough chemotype. Eur J Biochem (1988) 1.73
Studies of a receptor for felix O-1 phage in Salmonella minnesota. J Gen Microbiol (1967) 1.71
Molecular characterization of the O-acetyl transferase gene of converting bacteriophage SF6 that adds group antigen 6 to Shigella flexneri. Mol Microbiol (1991) 1.71
Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. Eur Respir J (1990) 1.69
Diagnosis of pneumococcal pneumonia: a comparison between microscopic examination of expectorate, antigen detection and cultural procedures. Scand J Infect Dis (1983) 1.68
Rapid grouping of streptococci by immunoelectroosmophoresis. Med Microbiol Immunol (1974) 1.67
Serological cross-reactions between different Brucella species and Yersinia enterocolitica. Immunochemical studies on phenol-water extracted lipopolysaccharides from Brucella abortus and Yersinia enterocolitica type IX. Acta Pathol Microbiol Scand B Microbiol Immunol (1973) 1.66
Quantitation of Salmonella O-antibodies in human sera by enzyme-linked immunosorbent assay (ELISA). Int Arch Allergy Appl Immunol (1975) 1.66
Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma. J Infect Dis (1995) 1.64
Use of monoclonal antibodies to type Shigella flexneri in Bangladesh. J Clin Microbiol (1989) 1.58
Identification of a chromosomal locus for expression of lipopolysaccharide epitopes in Haemophilus influenzae. Infect Immun (1989) 1.56
Concentration of chloramphenicol in the urine and blood in relation to renal function. Br Med J (1966) 1.55
Selective amplification of abequose and paratose synthase genes (rfb) by polymerase chain reaction for identification of Salmonella major serogroups (A, B, C2, and D). J Clin Microbiol (1993) 1.55
Risk of pneumonia in patients previously treated in hospital for pneumonia. Lancet (1992) 1.54
Monoclonal antibodies specific for O-antigenic polysaccharides of Shigella flexneri: clones binding to II, II:3,4, and 7,8 epitopes. J Clin Microbiol (1983) 1.53
Coupling of acid labile Salmonella specific oligosaccharides to macromolecular carriers. J Immunol Methods (1979) 1.52
Rough mutants of Salmonella typhimurium: immunochemical and structural analysis of lipopolysaccharides from rfaH mutants. J Gen Microbiol (1980) 1.51
Detection of Shigella dysenteriae type 1 and Shigella flexneri in feces by immunomagnetic isolation and polymerase chain reaction. J Clin Microbiol (1992) 1.49
Enzyme immunoassay of the antibody response to Brucella and Yersinia enterocolitica 09 infections in humans. J Hyg (Lond) (1982) 1.48
Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. J Infect Dis (2001) 1.47
Salmonella choleraesuis and Salmonella typhimurium associated with liver cells after intravenous inoculation of rats are localized mainly in Kupffer cells and multiply intracellularly. Infect Immun (1992) 1.47
Comparison of three stool-processing methods for detection of Salmonella serogroups B, C2, and D by PCR. J Clin Microbiol (1994) 1.46
Influence of O side chains on the attachment of the Felix O-1 bacteriophage to Salmonella bacteria. J Bacteriol (1969) 1.46
Hepatotoxicity due to repeated intake of low doses of paracetamol. J Intern Med (1992) 1.46
Pneumococcal serotypes and their clinical relevance. Thorax (1998) 1.40
Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization. J Bacteriol (1983) 1.40
Structural studies on the O-specific side-chains of the cell-wall lipopolysaccharide from Salmonella parathyphi A var. durazzo. Acta Chem Scand (1971) 1.39
Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia. Scand J Infect Dis (1995) 1.39
Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice. Infect Immun (1981) 1.38
Interaction between bacteriophage Sf6 and Shigella flexner. J Virol (1978) 1.38
Diagnosis of pneumococcal pneumonia by coagglutination and counterimmunoelectrophoresis of sputum samples. Eur J Clin Microbiol (1982) 1.37
In situ characterization of inflammatory responses in the rectal mucosae of patients with shigellosis. Infect Immun (1997) 1.36
Diagnosis of pneumococcal pneumonia by enzyme-linked immunosorbent assay of antibodies to pneumococcal hemolysin (pneumolysin). J Clin Microbiol (1987) 1.35
Bacteriophage attachment sites, serological specificity, and chemical composition of the lipopolysaccharides of semirough and rough mutants of Salmonella typhimurium. J Bacteriol (1971) 1.33
The gene H spike protein of bacteriophages phiX174 and S13. I. Functions in phage-receptor recognition and in transfection. Virology (1975) 1.32
Molecular characterization of the genes involved in O-antigen modification, attachment, integration and excision in Shigella flexneri bacteriophage SfV. Gene (1997) 1.30
Antigenic similarities in lipopolysaccharides of Haemophilus and Neisseria and expression of a digalactoside structure also present on human cells. Microb Pathog (1990) 1.30
Detection of antibodies in human serum against the fimbrial haemagglutinin of Bordetella pertussis by enzyme-linked immunosorbent assay. J Med Microbiol (1982) 1.30
Structural studies on the O-specific side-chains of the cell-wall lipopolysaccharide from Salmonella strasbourg. Acta Chem Scand (1970) 1.29
Structural studies on the O-specific side chains of the cell wall lipopolysaccharides from Salmonella typhi and S. enteritidis. Acta Chem Scand (1969) 1.26
Salmonella typhimurium infection in calves: specific immune reactivity against O-antigenic polysaccharide detectable in in vitro assays. Infect Immun (1982) 1.26
The role of Bacteroides fragilis in the pathogenesis of acute appendicitis. Acta Chir Scand (1982) 1.25
The lipopolysaccharide receptor for bacteriophage phiX174 and S13. Virology (1975) 1.24
Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries. J Infect Dis (2000) 1.23
Effect of synthetic disaccharide-protein conjugate as an immunogen in Salmonella infection in mice. Infect Immun (1974) 1.22
Nature, type of linkage, quantity, and absolute configuration of (3-hydroxy) fatty acids in lipopolysaccharides from Bacteroides fragilis NCTC 9343 and related strains. J Bacteriol (1980) 1.21
Salmonella typhimurium infection in calves: delayed specific skin reactions directed against the O-antigenic polysaccharide chain. Infect Immun (1982) 1.21
Role of monoclonal O-antigen antibody epitope specificity and isotype in protection against experimental mouse typhoid. Microb Pathog (1987) 1.20
Structural studies of the cell envelope lipopolysaccharides from Haemophilus ducreyi strains ITM 2665 and ITM 4747. J Biol Chem (1994) 1.18
Immunochemistry of Salmonella O-antigens: specificity of rabbit antibodies against the O-antigen 4 determinant elicited by whole bacteria and O-antigen 4 specific saccharide-protein conjugates. J Immunol (1979) 1.18
Turnover of nonencapsulated Haemophilus influenzae in the nasopharynges of otitis-prone children. J Clin Microbiol (1995) 1.18
The Shigella flexneri O-antigenic polysaccharide chain. Nature of the biological repeating unit. Eur J Biochem (1984) 1.18
Safety and immunogenicity study of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers. Vaccine (1995) 1.17
Efficient production of mouse and rat monoclonal antibodies against the O antigens of Salmonella serogroup C1, using LPS-coated bacteria as immunogen. J Immunol Methods (1990) 1.17
Salmonella dublin experimental infection in calves: protection after oral immunization with an auxotrophic aroA live vaccine. Zentralbl Veterinarmed B (1991) 1.17
Shigella flexneri O-antigen epitopes: chemical and immunochemical analyses reveal that epitopes of type III and group 6 antigens are identical. Infect Immun (1986) 1.16
Bacteriophage receptor development and synthesis of O-specific side chains after addition of D-galactose to the uridine diphosphate-galactose-4-epimeraseless mutant Salmonella typhimurium LT2-M1. J Bacteriol (1970) 1.16
Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections. Antimicrob Agents Chemother (1992) 1.15
Purification, characterization and HPLC assay of Salmonella glucose-1-phosphate thymidylyl-transferase from the cloned rfbA gene. Eur J Biochem (1993) 1.14
Extensive transmission of an isoniazid-resistant strain of Mycobacterium tuberculosis in Sweden. Int J Tuberc Lung Dis (2008) 1.13
Salmonella phage glycanases: substrate specificity of the phage P22 endo-rhamnosidase. J Gen Virol (1979) 1.12
Bacterial lipopolysaccharide in synovial fluid cells in Shigella triggered reactive arthritis. J Rheumatol (1992) 1.11
Characteristics of humoral and cellular immunity to Salmonella typhi in residents of typhoid-endemic and typhoid-free regions. J Infect Dis (1987) 1.10
Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden. Scand J Infect Dis Suppl (1983) 1.10
Age-specific prevalence of serum antibodies to the invasion plasmid and lipopolysaccharide antigens of Shigella species in Chilean and North American populations. J Infect Dis (1992) 1.09
Construction of aromatic dependent Shigella flexneri 2a live vaccine candidate strains: deletion mutations in the aroA and the aroD genes. Vaccine (1991) 1.09
Live oral auxotrophic Shigella flexneri SFL124 vaccine with a deleted aroD gene: characterization and monkey protection studies. Vaccine (1992) 1.08
Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in volunteers. Vaccine (1992) 1.08
Bacterial virulence factors--with particular reference to Salmonella bacteria. Scand J Infect Dis Suppl (1980) 1.08
Introduction and spread of multi-resistant Shigella dysenteriae I in Thailand. Am J Trop Med Hyg (1989) 1.07
Structural studies of the saccharide part of the cell envelope lipopolysaccharide from Haemophilus influenzae strain AH1-3 (lic3+). Carbohydr Res (1993) 1.07